AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Tricia Bishop
May 02--If there's one thing parents of toddlers know, it's this: Vaccination shots are the pits. They're scary, they leave a mark, and -- worst of all -- they hurt. "The vast majority of kids would prefer not to have the pain," acknowledged Dr. Daniel Levy, an Owings Mills pediatrician and president of the Maryland chapter of the American Academy of Pediatrics.
That fact is among the chief motivating factors behind MedImmune Inc.'s quest to improve its inhaled flu vaccine called FluMist, which has thus far been a disappointment for the Gaithersburg company's investors.
The original formula, sanctioned for sale in 2003, is approved for use only in healthy people ages 5 to 49. Capturing the groups under and over that age range -- those most at risk from flu complications…
Source: HighBeam Research, Positive results presented for new FluMist: MedImmune seeks OK for...